Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2012

Open Access 01-12-2012 | Research article

The modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: a pilot study

Authors: Claire Launois, Coralie Barbe, Eric Bertin, Julie Nardi, Jeanne-Marie Perotin, Sandra Dury, François Lebargy, Gaëtan Deslee

Published in: BMC Pulmonary Medicine | Issue 1/2012

Login to get access

Abstract

Background

Dyspnea is very frequent in obese subjects. However, its assessment is complex in clinical practice. The modified Medical Research Council scale (mMRC scale) is largely used in the assessment of dyspnea in chronic respiratory diseases, but has not been validated in obesity. The objectives of this study were to evaluate the use of the mMRC scale in the assessment of dyspnea in obese subjects and to analyze its relationships with the 6-minute walk test (6MWT), lung function and biological parameters.

Methods

Forty-five obese subjects (17 M/28 F, BMI: 43 ± 9 kg/m2) were included in this pilot study. Dyspnea in daily living was evaluated by the mMRC scale and exertional dyspnea was evaluated by the Borg scale after 6MWT. Pulmonary function tests included spirometry, plethysmography, diffusing capacity of carbon monoxide and arterial blood gases. Fasting blood glucose, total cholesterol, triglyceride, N-terminal pro brain natriuretic peptide, C-reactive protein and hemoglobin levels were analyzed.

Results

Eighty-four percent of patients had a mMRC ≥ 1 and 40% a mMRC ≥ 2. Compared to subjects with no dyspnea (mMRC = 0), a mMRC ≥ 1 was associated with a higher BMI (44 ± 9 vs 36 ± 5 kg/m2, p = 0.01), and a lower expiratory reserve volume (ERV) (50 ± 31 vs 91 ± 32%, p = 0.004), forced expiratory volume in one second (FEV1) (86 ± 17 vs 101 ± 16%, p = 0.04) and distance covered in 6MWT (401 ± 107 vs 524 ± 72 m, p = 0.007). A mMRC ≥ 2 was associated with a higher Borg score after the 6MWT (4.7 ± 2.5 vs 6.5 ± 1.5, p < 0.05).

Conclusion

This study confirms that dyspnea is very frequent in obese subjects. The differences between the “dyspneic” and the “non dyspneic” groups assessed by the mMRC scale for BMI, ERV, FEV1 and distance covered in 6MWT suggests that the mMRC scale might be an useful and easy-to-use tool to assess dyspnea in daily living in obese subjects.
Appendix
Available only for authorised users
Literature
2.
go back to reference Sjöström L, Larsson B, Backman L, Bengtsson C, Bouchard C, Dahlgren S, Hallgren P, Jonsson E, Karlsson J, Lapidus L: Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord. 1992, 16: 465-479.PubMed Sjöström L, Larsson B, Backman L, Bengtsson C, Bouchard C, Dahlgren S, Hallgren P, Jonsson E, Karlsson J, Lapidus L: Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord. 1992, 16: 465-479.PubMed
3.
go back to reference Collet F, Mallart A, Bervar JF, Bautin N, Matran R, Pattou F, Romon M, Perez T: Physiologic correlates of dyspnea in patients with morbid obesity. Int J Obes (Lond). 2007, 31: 700-706. Collet F, Mallart A, Bervar JF, Bautin N, Matran R, Pattou F, Romon M, Perez T: Physiologic correlates of dyspnea in patients with morbid obesity. Int J Obes (Lond). 2007, 31: 700-706.
4.
go back to reference Salome CM, King GG, Berend N: Physiology of obesity and effects on lung function. J Appl Physiol. 2010, 108: 206-211. 10.1152/japplphysiol.00694.2009.CrossRefPubMed Salome CM, King GG, Berend N: Physiology of obesity and effects on lung function. J Appl Physiol. 2010, 108: 206-211. 10.1152/japplphysiol.00694.2009.CrossRefPubMed
6.
go back to reference Ray CS, Sue DY, Bray G, Hansen JE, Wasserman K: Effects of obesity on respiratory function. Am Rev Respir Dis. 1983, 128: 501-506.CrossRefPubMed Ray CS, Sue DY, Bray G, Hansen JE, Wasserman K: Effects of obesity on respiratory function. Am Rev Respir Dis. 1983, 128: 501-506.CrossRefPubMed
7.
go back to reference Jones RL, Nzekwu M-MU: The effects of body mass index on lung volumes. Chest. 2006, 130: 827-833. 10.1378/chest.130.3.827.CrossRefPubMed Jones RL, Nzekwu M-MU: The effects of body mass index on lung volumes. Chest. 2006, 130: 827-833. 10.1378/chest.130.3.827.CrossRefPubMed
8.
go back to reference Biring MS, Lewis MI, Liu JT, Mohsenifar Z: Pulmonary physiologic changes of morbid obesity. Am J Med Sci. 1999, 318: 293-297. 10.1097/00000441-199911000-00002.CrossRefPubMed Biring MS, Lewis MI, Liu JT, Mohsenifar Z: Pulmonary physiologic changes of morbid obesity. Am J Med Sci. 1999, 318: 293-297. 10.1097/00000441-199911000-00002.CrossRefPubMed
9.
go back to reference Babb TG, Ranasinghe KG, Comeau LA, Semon TL, Schwartz B: Dyspnea on exertion in obese women: association with an increased oxygen cost of breathing. Am J Respir Crit Care Med. 2008, 178: 116-123. 10.1164/rccm.200706-875OC.CrossRefPubMed Babb TG, Ranasinghe KG, Comeau LA, Semon TL, Schwartz B: Dyspnea on exertion in obese women: association with an increased oxygen cost of breathing. Am J Respir Crit Care Med. 2008, 178: 116-123. 10.1164/rccm.200706-875OC.CrossRefPubMed
10.
11.
go back to reference Ofir D, Laveneziana P, Webb KA, O’Donnell DE: Ventilatory and perceptual responses to cycle exercise in obese women. J Appl Physiol. 2007, 102: 2217-2226. 10.1152/japplphysiol.00898.2006.CrossRefPubMed Ofir D, Laveneziana P, Webb KA, O’Donnell DE: Ventilatory and perceptual responses to cycle exercise in obese women. J Appl Physiol. 2007, 102: 2217-2226. 10.1152/japplphysiol.00898.2006.CrossRefPubMed
12.
go back to reference Romagnoli I, Laveneziana P, Clini EM, Palange P, Valli G, de Blasio F, Gigliotti F, Scano G: Role of hyperinflation vs. deflation on dyspnoea in severely to extremely obese subjects. Acta Physiol (Oxf). 2008, 193: 393-402. 10.1111/j.1748-1716.2008.01852.x.CrossRef Romagnoli I, Laveneziana P, Clini EM, Palange P, Valli G, de Blasio F, Gigliotti F, Scano G: Role of hyperinflation vs. deflation on dyspnoea in severely to extremely obese subjects. Acta Physiol (Oxf). 2008, 193: 393-402. 10.1111/j.1748-1716.2008.01852.x.CrossRef
13.
go back to reference Jensen D, Webb KA, Wolfe LA, O’Donnell DE: Effects of human pregnancy and advancing gestation on respiratory discomfort during exercise. Respir Physiol Neurobiol. 2007, 156: 85-93. 10.1016/j.resp.2006.08.004.CrossRefPubMed Jensen D, Webb KA, Wolfe LA, O’Donnell DE: Effects of human pregnancy and advancing gestation on respiratory discomfort during exercise. Respir Physiol Neurobiol. 2007, 156: 85-93. 10.1016/j.resp.2006.08.004.CrossRefPubMed
14.
go back to reference Scano G, Stendardi L, Bruni GI: The respiratory muscles in eucapnic obesity: their role in dyspnea. Respir Med. 2009, 103: 1276-1285. 10.1016/j.rmed.2009.03.023.CrossRefPubMed Scano G, Stendardi L, Bruni GI: The respiratory muscles in eucapnic obesity: their role in dyspnea. Respir Med. 2009, 103: 1276-1285. 10.1016/j.rmed.2009.03.023.CrossRefPubMed
15.
go back to reference Ora J, Laveneziana P, Ofir D, Deesomchok A, Webb KA, O’Donnell DE: Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance. Am J Respir Crit Care Med. 2009, 180: 964-971.CrossRefPubMed Ora J, Laveneziana P, Ofir D, Deesomchok A, Webb KA, O’Donnell DE: Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance. Am J Respir Crit Care Med. 2009, 180: 964-971.CrossRefPubMed
16.
go back to reference Sava F, Laviolette L, Bernard S, Breton M-J, Bourbeau J, Maltais F: The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med. 2010, 10: 55-10.1186/1471-2466-10-55.CrossRefPubMedPubMedCentral Sava F, Laviolette L, Bernard S, Breton M-J, Bourbeau J, Maltais F: The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med. 2010, 10: 55-10.1186/1471-2466-10-55.CrossRefPubMedPubMedCentral
17.
go back to reference Lecube A, Sampol G, Muñoz X, Hernández C, Mesa J, Simó R: Type 2 diabetes impairs pulmonary function in morbidly obese women: a case-control study. Diabetologia. 2010, 53: 1210-1216. 10.1007/s00125-010-1700-5.CrossRefPubMed Lecube A, Sampol G, Muñoz X, Hernández C, Mesa J, Simó R: Type 2 diabetes impairs pulmonary function in morbidly obese women: a case-control study. Diabetologia. 2010, 53: 1210-1216. 10.1007/s00125-010-1700-5.CrossRefPubMed
18.
go back to reference Lecube A, Sampol G, Muñoz X, Lloberes P, Hernández C, Simó R: Insulin resistance is related to impaired lung function in morbidly obese women: a case-control study. Diabetes Metab Res Rev. 2010, 26: 639-645. 10.1002/dmrr.1131.CrossRefPubMed Lecube A, Sampol G, Muñoz X, Lloberes P, Hernández C, Simó R: Insulin resistance is related to impaired lung function in morbidly obese women: a case-control study. Diabetes Metab Res Rev. 2010, 26: 639-645. 10.1002/dmrr.1131.CrossRefPubMed
19.
go back to reference Leone N, Courbon D, Thomas F, Bean K, Jégo B, Leynaert B, Guize L, Zureik M: Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med. 2009, 179: 509-516. 10.1164/rccm.200807-1195OC.CrossRefPubMed Leone N, Courbon D, Thomas F, Bean K, Jégo B, Leynaert B, Guize L, Zureik M: Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med. 2009, 179: 509-516. 10.1164/rccm.200807-1195OC.CrossRefPubMed
20.
go back to reference Mahler DA, Wells CK: Evaluation of clinical methods for rating dyspnea. Chest. 1988, 93: 580-586. 10.1378/chest.93.3.580.CrossRefPubMed Mahler DA, Wells CK: Evaluation of clinical methods for rating dyspnea. Chest. 1988, 93: 580-586. 10.1378/chest.93.3.580.CrossRefPubMed
21.
go back to reference Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T: Analysis of Clinical Methods Used to Evaluate Dyspnea in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 1998, 158: 1185-1189.CrossRefPubMed Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T: Analysis of Clinical Methods Used to Evaluate Dyspnea in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 1998, 158: 1185-1189.CrossRefPubMed
22.
go back to reference Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Kataoka K, Ogawa T, Watanabe F, Arizono S: A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur Respir J. 2010, 36: 1067-1072. 10.1183/09031936.00152609.CrossRefPubMed Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Kataoka K, Ogawa T, Watanabe F, Arizono S: A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur Respir J. 2010, 36: 1067-1072. 10.1183/09031936.00152609.CrossRefPubMed
23.
go back to reference ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002, 166: 111-117. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002, 166: 111-117.
24.
go back to reference Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J Suppl. 1993, 16: 1-100. Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J Suppl. 1993, 16: 1-100.
25.
go back to reference Eltayara L, Becklake MR, Volta CA, Milic-Emili J: Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996, 154: 1726-1734.CrossRefPubMed Eltayara L, Becklake MR, Volta CA, Milic-Emili J: Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996, 154: 1726-1734.CrossRefPubMed
26.
go back to reference Gerlach Y, Williams MT, Coates AM: Weighing up the evidence-a systematic review of measures used for the sensation of breathlessness in obesity. Int J Obes. 2012 Gerlach Y, Williams MT, Coates AM: Weighing up the evidence-a systematic review of measures used for the sensation of breathlessness in obesity. Int J Obes. 2012
27.
go back to reference El-Gamal H, Khayat A, Shikora S, Unterborn JN: Relationship of dyspnea to respiratory drive and pulmonary function tests in obese patients before and after weight loss. Chest. 2005, 128: 3870-3874. 10.1378/chest.128.6.3870.CrossRefPubMed El-Gamal H, Khayat A, Shikora S, Unterborn JN: Relationship of dyspnea to respiratory drive and pulmonary function tests in obese patients before and after weight loss. Chest. 2005, 128: 3870-3874. 10.1378/chest.128.6.3870.CrossRefPubMed
28.
go back to reference Mahler DA, Weinberg DH, Wells CK, Feinstein AR: The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984, 85: 751-758. 10.1378/chest.85.6.751.CrossRefPubMed Mahler DA, Weinberg DH, Wells CK, Feinstein AR: The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984, 85: 751-758. 10.1378/chest.85.6.751.CrossRefPubMed
29.
go back to reference Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM: Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest. 1998, 113: 619-624. 10.1378/chest.113.3.619.CrossRefPubMed Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM: Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest. 1998, 113: 619-624. 10.1378/chest.113.3.619.CrossRefPubMed
31.
go back to reference Sin DD, Jones RL, Man SFP: Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med. 2002, 162: 1477-1481. 10.1001/archinte.162.13.1477.CrossRefPubMed Sin DD, Jones RL, Man SFP: Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med. 2002, 162: 1477-1481. 10.1001/archinte.162.13.1477.CrossRefPubMed
32.
go back to reference Beriault K, Carpentier AC, Gagnon C, Ménard J, Baillargeon J-P, Ardilouze J-L, Langlois M-F: Reproducibility of the 6-minute walk test in obese adults. Int J Sports Med. 2009, 30: 725-727. 10.1055/s-0029-1231043.CrossRefPubMed Beriault K, Carpentier AC, Gagnon C, Ménard J, Baillargeon J-P, Ardilouze J-L, Langlois M-F: Reproducibility of the 6-minute walk test in obese adults. Int J Sports Med. 2009, 30: 725-727. 10.1055/s-0029-1231043.CrossRefPubMed
33.
go back to reference Larsson UE, Reynisdottir S: The six-minute walk test in outpatients with obesity: reproducibility and known group validity. Physiother Res Int. 2008, 13: 84-93. 10.1002/pri.398.CrossRefPubMed Larsson UE, Reynisdottir S: The six-minute walk test in outpatients with obesity: reproducibility and known group validity. Physiother Res Int. 2008, 13: 84-93. 10.1002/pri.398.CrossRefPubMed
Metadata
Title
The modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: a pilot study
Authors
Claire Launois
Coralie Barbe
Eric Bertin
Julie Nardi
Jeanne-Marie Perotin
Sandra Dury
François Lebargy
Gaëtan Deslee
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2012
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-12-61

Other articles of this Issue 1/2012

BMC Pulmonary Medicine 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.